| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8341127 | Microvascular Research | 2015 | 5 Pages |
Abstract
The TLR4 pathway may be a target in clinical Gram-negative sepsis since administration of the TLR4 antagonist CRX-526 improved intestinal microcirculation parameters in experimental endotoxemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Juan Zhou, Marieke Soltow, Katrin Zimmermann, Dragan Pavlovic, Brent Johnston, Christian Lehmann,